Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
50.17
+0.04 (0.08%)
Jun 6, 2025, 3:00 PM CST

SHA:688076 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
11,28211,4119,5834,8908,811-
Upgrade
Market Cap Growth
15.03%19.08%95.95%-44.50%--
Upgrade
Enterprise Value
12,36712,1079,7724,7268,238-
Upgrade
Last Close Price
50.1751.9244.5822.6340.53-
Upgrade
PE Ratio
22.5628.2258.8137.8876.36-
Upgrade
Forward PE
19.3020.2550.6531.8642.28-
Upgrade
PS Ratio
6.157.029.277.5113.68-
Upgrade
PB Ratio
3.984.254.382.544.87-
Upgrade
P/TBV Ratio
4.414.765.042.955.64-
Upgrade
P/OCF Ratio
24.1628.5227.36166.9548.75-
Upgrade
EV/Sales Ratio
6.747.459.467.2612.79-
Upgrade
EV/EBITDA Ratio
15.4416.6430.3127.7241.45-
Upgrade
EV/EBIT Ratio
21.5423.0551.1565.8470.35-
Upgrade
Debt / Equity Ratio
0.640.610.410.170.050.26
Upgrade
Debt / EBITDA Ratio
-2.252.741.860.411.23
Upgrade
Debt / FCF Ratio
-----8.24
Upgrade
Asset Turnover
0.400.380.340.280.370.43
Upgrade
Inventory Turnover
2.401.091.271.071.411.66
Upgrade
Quick Ratio
0.690.761.081.262.990.69
Upgrade
Current Ratio
1.061.141.541.914.011.28
Upgrade
Return on Equity (ROE)
18.96%16.41%8.04%6.58%7.84%13.30%
Upgrade
Return on Assets (ROA)
7.79%7.61%3.93%1.93%4.15%6.22%
Upgrade
Return on Capital (ROIC)
8.96%8.86%4.48%2.17%4.71%7.28%
Upgrade
Return on Capital Employed (ROCE)
16.00%15.80%7.40%3.60%6.30%13.00%
Upgrade
Earnings Yield
4.35%3.54%1.70%2.64%1.31%-
Upgrade
FCF Yield
-7.17%-6.05%-3.24%-8.37%-0.60%-
Upgrade
Dividend Yield
1.79%-0.90%0.88%0.37%-
Upgrade
Payout Ratio
25.37%29.37%35.36%31.43%5.24%-
Upgrade
Buyback Yield / Dilution
-0.05%-2.51%-1.29%-10.05%-19.96%1.06%
Upgrade
Total Shareholder Return
1.74%-2.51%-0.40%-9.17%-19.59%1.06%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.